The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

Cigna has sold its Medicare businesses and slashed the number of people it covers in its ACA plans by more than half.

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...

Prescription denial rates from private insurers grew from 18.3% in 2016 to 22.9% in 2023 — a 25% increase, according to a July 18 article from The New York Times.  Healthcare analytics company Komodo ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

Senators grilled Novo Nordisk CEO Lars Jrgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs, requesting explanations for why the U.S. faces a higher list ...